Cover Image

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

Show other versions (1)

There is a growing body of evidence that HER2 status can change during disease recurrence or progression in breast cancer patients. In this context, re-evaluation of HER2 status by assessment of HER2 expression on circulating tumor cells (CTCs) is …

Saved in:
Bibliographic Details
Main Authors: Fehm, Tanja (Author) , Aktaş, Bahriye (Author) , Janni, Wolfgang (Author) , Schneeweiss, Andreas (Author) , Stickeler, Elmar (Author) , Lattrich, Claus Richard (Author) , Löhberg, Christian R. (Author) , Solomayer, Erich-Franz (Author) , Rack, Brigitte K. (Author) , Riethdorf, Sabine (Author) , Klein, Christoph (Author) , Schindlbeck, Christian (Author) , Brocker, Kerstin A. (Author) , Kasimir-Bauer, Sabine (Author) , Wallwiener, Diethelm (Author) , Pantel, Klaus (Author)
Format: Article (Journal)
Language:German
Published: 01.11.2010
In: Breast cancer research and treatment
Year: 2010, Volume: 124, Issue: 2, Pages: 403-412
ISSN:1573-7217
Online Access:Verlag, lizenzpflichtig, Volltext: https://www.springermedizin.de/her2-status-of-circulating-tumor-cells-in-patients-with-metastat/8842548
Get full text
Author Notes:Tanja Fehm, Volkmar Müller, Bahriye Aktas, Wolfgang Janni, Andreas Schneeweiss, Elmar Stickeler, Claus Lattrich, Christian R. Löhberg, Erich Solomayer, Brigitte Rack, Sabine Riethdorf, Christoph Klein, Christian Schindlbeck, Kerstin Brocker, Sabine Kasimir-Bauer, Diethelm Wallwiener, Klaus Pantel
Description
Summary:There is a growing body of evidence that HER2 status can change during disease recurrence or progression in breast cancer patients. In this context, re-evaluation of HER2 status by assessment of HER2 expression on circulating tumor cells (CTCs) is …
Item Description:Gesehen am 23.03.2020
Physical Description:Online Resource
ISSN:1573-7217

Similar Items